1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
- 2015
-
Mark
Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
(
- Contribution to journal › Article
-
Mark
SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
(
- Contribution to journal › Article
- 2012
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study.
(
- Contribution to journal › Article
-
Mark
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
(
- Contribution to journal › Article